Spring A Silva, NP
Nurse Practitioner · Santa Cruz
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 14 years
- Graduated 2012
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Spring A Silva’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$40,407
Medicare paid this office $40,407 for 285 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 227 | $29,363 | $93 |
| Return visit (30+ min) | 106 | $8,133 | $61 |
| New patient visit (45+ min) | 11 | $782 | $71 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 21 | $450 | $21 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 29 | $342 | $11 |
Who their Medicare patients are
285 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 6% · Women 74% · Also on Medicaid 36% · Health risk score 1.76. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 74% · Depression 34% · Coronary heart disease 33% · Diabetes 32% · Chronic kidney disease 29% · Heart failure 24% · COPD 22% · Atrial fibrillation 20% · Cancer 15% · Stroke 9% · Dementia 5%.
The office billed $309,408, Medicare allowed $55,467 and paid $40,407; for 539 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 285 | 539 | 72 | 1.76 | $309,408 | $40,407 |
| 2023 | 298 | 556 | 71 | 1.70 | $336,261 | $46,009 |
| 2022 | 194 | 251 | 73 | 1.24 | $120,725 | $23,238 |
| 2021 | 145 | 169 | 76 | 1.10 | $68,950 | $18,753 |
| 2020 | 49 | 53 | 73 | 1.24 | $16,454 | $3,577 |
| 2019 | 93 | 107 | 76 | 1.11 | $31,952 | $7,856 |
| 2018 | 43 | 54 | 75 | 1.30 | $15,540 | $3,480 |
| 2017 | 144 | 307 | 67 | 1.01 | $78,582 | $17,439 |
| 2016 | 179 | 223 | 63 | 1.57 | $76,181 | $14,051 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Long return visit (40+ min) | 228 | $29,479 | $97 |
| Return visit (30+ min) | 127 | $13,032 | $66 |
| New patient visit (45+ min) | 15 | $1,375 | $92 |
2022: 5 services
| Long return visit (40+ min) | 54 | $8,833 | $134 |
| Return visit (30+ min) | 95 | $8,123 | $72 |
| New patient visit (45+ min) | 35 | $3,966 | $113 |
| New patient visit (30+ min) | 13 | $756 | $58 |
| Short return visit (20+ min) | 15 | $750 | $47 |
2021: 3 services
| Return visit (30+ min) | 71 | $8,001 | $100 |
| New patient visit (45+ min) | 39 | $4,587 | $118 |
| Long return visit (40+ min) | 27 | $4,237 | $146 |
2020: 2 services
| Return visit (30+ min) | 17 | $1,074 | $63 |
| Short return visit (20+ min) | 16 | $985 | $62 |
2019: 3 services
| Return visit (30+ min) | 24 | $2,227 | $86 |
| Short return visit (20+ min) | 35 | $2,042 | $57 |
| New patient visit (45+ min) | 12 | $1,430 | $119 |
2018: 2 services
| Return visit (30+ min) | 13 | $940 | $72 |
| Short return visit (20+ min) | 12 | $640 | $53 |
2017: 9 services
| New patient visit (45+ min) | 30 | $3,440 | $115 |
| Return visit (30+ min) | 28 | $2,541 | $82 |
| New patient visit (30+ min) | 18 | $1,505 | $84 |
| Emergency department visit with low level of medical decision making | 26 | $1,089 | $42 |
| Short return visit (20+ min) | 20 | $1,084 | $54 |
| X-ray of chest, 2 views, front and side | 19 | $434 | $23 |
| Injection of drug or substance under skin or into muscle | 13 | $275 | $21 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $175 | $16 |
| Automated urinalysis test | 12 | $36 | $3 |
2016: 4 services
| Emergency department visit with high level of medical decision making | 40 | $4,862 | $122 |
| Emergency department visit with moderate level of medical decision making | 55 | $4,495 | $82 |
| Emergency department visit with low level of medical decision making | 79 | $3,369 | $43 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | $143 | $6 |
Medicaid work
$1,021 in 2024
Medicaid paid $1,021 for 25 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 25 | $1,021 |
| 2024 | 25 | 1 | 13 | $1,021 |
| 2023 | 25 | 1 | 13 | $1,679 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 25 | $1,679 |
Drugs they prescribed that Part D paid
$383,453
Pharmacies billed $383,453 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,303) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
795 generic and 508 brand-name prescriptions · $383,453 in drug cost · 25 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 160 | $116,555 | $728 |
| Zenpep | 16 | $55,542 | $3,471 |
| Motegrity | 62 | $50,493 | $814 |
| Trulance | 67 | $43,437 | $648 |
| Creon | 12 | $29,986 | $2,499 |
See all 19 drugs
| Linzess | 160 | $116,555 | $728 |
| Zenpep | 16 | $55,542 | $3,471 |
| Motegrity | 62 | $50,493 | $814 |
| Trulance | 67 | $43,437 | $648 |
| Creon | 12 | $29,986 | $2,499 |
| Lubiprostone | 141 | $15,680 | $111 |
| Sucralfate | 82 | $5,036 | $61 |
| Dexlansoprazole Dr | 19 | $4,385 | $231 |
| Famotidine | 204 | $2,312 | $11 |
| Omeprazole | 110 | $1,410 | $13 |
| Lansoprazole | 11 | $1,345 | $122 |
| Pantoprazole | 85 | $1,315 | $15 |
| Ondansetron Odt | 44 | $709 | $16 |
| Diltiazem | 31 | $606 | $20 |
| Gavilyte-G | 15 | $569 | $38 |
| Dicyclomine | 20 | $317 | $16 |
| Promethazine | 11 | $242 | $22 |
| Diphenoxylate-Atropine | 19 | $211 | $11 |
| Metoclopramide | 23 | $188 | $8 |
Year by year
| 2024 | 1,303 | 250 | 0% (0) | 39% | $383,453 |
| 2023 | 1,015 | 244 | 0% (0) | 39% | $315,017 |
| 2022 | 310 | 146 | 0% (0) | 32% | $60,755 |
| 2021 | 225 | 90 | None | 32% | $44,664 |
| 2020 | 99 | 35 | None | 20% | $19,436 |
| 2019 | 136 | 70 | None | 21% | $12,577 |
| 2018 | 37 | 24 | None | None | $909 |
| 2017 | 168 | 122 | 10% (17) | None | $2,545 |
| 2016 | 119 | 82 | 16% (19) | 11% | $1,350 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Linzess | 179 | $108,851 | $608 |
| Xifaxan | 23 | $53,086 | $2,308 |
| Motegrity | 42 | $32,179 | $766 |
| Trulance | 48 | $31,104 | $648 |
| Lubiprostone | 50 | $10,195 | $204 |
| Dexlansoprazole Dr | 19 | $4,364 | $230 |
| Sucralfate | 77 | $4,363 | $57 |
| Cholestyramine Light | 11 | $1,770 | $161 |
| Omeprazole | 103 | $1,604 | $16 |
| Famotidine | 90 | $1,588 | $18 |
| Diphenoxylate-Atropine | 25 | $1,430 | $57 |
| Diltiazem | 28 | $1,133 | $40 |
| Dicyclomine | 24 | $950 | $40 |
| Pantoprazole | 50 | $913 | $18 |
| Ondansetron Odt | 42 | $770 | $18 |
| Loperamide | 16 | $566 | $35 |
| Metoclopramide | 21 | $144 | $7 |
| Metronidazole | 12 | $89 | $7 |
2022: 6 drugs
| Linzess | 32 | $16,640 | $520 |
| Suprep | 22 | $2,549 | $116 |
| Sucralfate | 17 | $915 | $54 |
| Omeprazole | 52 | $652 | $13 |
| Pantoprazole | 28 | $646 | $23 |
| Famotidine | 24 | $420 | $17 |
2021: 7 drugs
| Linzess | 25 | $14,755 | $590 |
| Suprep | 11 | $1,199 | $109 |
| Ondansetron Odt | 15 | $780 | $52 |
| Omeprazole | 38 | $644 | $17 |
| Famotidine | 21 | $413 | $20 |
| Sucralfate | 15 | $379 | $25 |
| Pantoprazole | 18 | $320 | $18 |
2020: 2 drugs
| Pantoprazole | 25 | $318 | $13 |
| Omeprazole | 16 | $189 | $12 |
2019: 3 drugs
| Suprep | 13 | $1,290 | $99 |
| Pantoprazole | 32 | $520 | $16 |
| Ranitidine | 13 | $108 | $8 |
2018: 1 drug
| Omeprazole | 11 | $152 | $14 |
2017: 5 drugs
| Cephalexin | 19 | $200 | $11 |
| Doxycycline Monohydrate | 11 | $125 | $11 |
| Sulfamethoxazole-Trimethoprim | 14 | $92 | $7 |
| Azithromycin | 13 | $69 | $5 |
| Hydrocodone-Acetaminophen | 12 | $60 | $5 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 16 | $78 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $54 | $5 |
Money from drug and device companies
$306 in 2024
A payment is not proof that care is biased.
| Gilead Sciences | Epclusa | $115 | 1 payment
|
| Genzyme | Dupixent | $112 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $79 | 1 payment
|
See all 3 published payments
| Gilead Sciences | Meals · 2024-07-10 | Epclusa | $115 |
| Genzyme | Meals · 2024-05-29 | Dupixent | $112 |
| Janssen Pharmaceuticals | Meals · 2024-03-13 | Xarelto | $79 |
Professional record
- NPI
- 1497094049
- Licence
- CA 791722
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2013-02-01
- NPI last updated
- 2024-12-03
- NPI record certified
- 2024-12-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5325 Broder Blvd, Dublin, CA, 94568 · 3160 Folsom Blvd, Sacramento, CA, 95816 · 301 Industrial Rd, San Carlos, CA, 94070